BSE filing, NSE: SW1. Summary written from the filing by ALFA Finder's alert engine.
SW Investments Ltd: key numbers
- Share price
- ₹248.95
- Market cap
- ₹22.41 Cr
- Revenue (annual)
- ₹0.43 Cr
- Net profit (annual)
- ₹0.24 Cr
- P/E (TTM)
- 84.0×Sector 19.7×
- Promoter holding
- 42.78%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from SW Investments Ltd
All →SW Investments Annual General Meeting
SW Investments Limited held its 46th Annual General Meeting on 18th September, 2026. The meeting was conducted via video conferencing for all shareholders.
SW Investments Capital Structure Change
Hal Clyde Denison Limited acquired 19,451 shares (2.161% stake) of SW Investments Limited via an off-market transaction. The acquirer's total stake increased to 6.189%.
SW Investments Annual General Meeting
SW Investments Limited announced the scheduling of its 46th Annual General Meeting on 18th September, 2026, with a cut-off date of 11th September, 2026.
SW Investments Q1 FY27 Results: Net Profit ₹0.1 Cr, Up 0.0% QoQ
SW Investments Ltd reported revenue from operations of ₹0.1 Cr (+0.0% YoY) and net profit of ₹0.1 Cr for Q1 FY27.
- Key figure
- Net profit ₹0.1 Cr
SW Investments Board Meeting Date
SW Investments Limited has scheduled a board meeting on 11th August, 2026, to approve the unaudited financial results for the quarter ended 30th June, 2026.
SW Investments Q4 FY26 Results: Net Profit ₹0.1 Cr, Up 0.0% QoQ
SW Investments Ltd reported revenue from operations of ₹0.1 Cr (+0.0% YoY) and net profit of ₹0.1 Cr for Q4 FY26.
- Key figure
- Net profit ₹0.1 Cr
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.